RAYNE ROUCE to Risk Assessment
This is a "connection" page, showing publications RAYNE ROUCE has written about Risk Assessment.
Connection Strength
0.108
-
Gene Therapy: Current Applications and Future Possibilities. Adv Pediatr. 2019 08; 66:37-54.
Score: 0.078
-
Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel. Blood Adv. 2025 Oct 14; 9(19):5070-5084.
Score: 0.030